Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-13

Clinical Trial Update: Biomarkers of Diet-microbiota Interactions in Irritable Bowel Syndrome [EARLY_Phase 1]

View source ↗

Summary

This early-phase 1 clinical trial examining biomarkers of diet-microbiota interactions in irritable bowel syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: McMaster University | Conditions: Irritable Bowel Syndrome | EARLY_Phase 1 | Status: COMPLETED